Literature DB >> 12819257

Chymase: a potential culprit in diabetic nephropathy?

Eberhard Ritz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12819257     DOI： 10.1097/01.asn.0000076125.12092.c6

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  12 in total

Review 1.  Renal effects of dual renin-angiotensin-aldosterone system blockade in patients with diabetic nephropathy.

Authors:  M Dalla Vestra; N Simioni; A Masiero
Journal:  Int Urol Nephrol       Date:  2008-10-29       Impact factor: 2.370

Review 2.  Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases.

Authors:  Aina He; Guo-Ping Shi
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

3.  Chymase increases glomerular albumin permeability via protease-activated receptor-2.

Authors:  Ram Sharma; Vidudala Prasad; Ellen T McCarthy; Virginia J Savin; Kottarappat N Dileepan; Daniel J Stechschulte; Elias Lianos; Thomas Wiegmann; Mukut Sharma
Journal:  Mol Cell Biochem       Date:  2006-11-11       Impact factor: 3.396

4.  Differential expression of the angiotensin-(1-12)/chymase axis in human atrial tissue.

Authors:  Sayaka Nagata; Jasmina Varagic; Neal D Kon; Hao Wang; Leanne Groban; Stephen W Simington; Sarfaraz Ahmad; Louis J Dell'Italia; Jessica L VonCannon; Dwight Deal; Carlos M Ferrario
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-06-16

5.  Enhanced vascular chymase-dependent conversion of endothelin in the diabetic kidney.

Authors:  Lisa M Harrison-Bernard; Lawrence de Garavilla; Benjamin J Bivona
Journal:  Ochsner J       Date:  2013

6.  Direct evidence for intrarenal chymase-dependent angiotensin II formation on the diabetic renal microvasculature.

Authors:  Sungmi Park; Benjamin J Bivona; Stephen M Ford; Sen Xu; Hiroyuki Kobori; Lawrence de Garavilla; Lisa M Harrison-Bernard
Journal:  Hypertension       Date:  2012-12-03       Impact factor: 10.190

7.  Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications.

Authors:  Vijay Koka; Wansheng Wang; Xiao Ru Huang; Shokei Kim-Mitsuyama; Luan D Truong; Hui Y Lan
Journal:  Circulation       Date:  2006-03-06       Impact factor: 29.690

Review 8.  Do resident renal mast cells play a role in the pathogenesis of diabetic nephropathy?

Authors:  Pitchai Balakumar; Jayarami Reddy; Manjeet Singh
Journal:  Mol Cell Biochem       Date:  2009-05-05       Impact factor: 3.396

9.  Different roles of mast cells in obesity and diabetes: lessons from experimental animals and humans.

Authors:  Michael A Shi; Guo-Ping Shi
Journal:  Front Immunol       Date:  2012-01-25       Impact factor: 7.561

Review 10.  Reducing cardiovascular events in high-risk patients: the challenge of managing hypertension in patients with diabetic renal disease.

Authors:  Robert D Toto
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-11       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.